Not Medicare Enrolled

Dr. Julie Linderman, MD

Student in an Organized Health Care Education/Training Program · Dallas, TX
5470 W LOVERS LN STE 330, Dallas, TX 75209
2144567000
Registered in NPPES since 2007
NPI: 1992907240 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Linderman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Linderman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Linderman

Dr. Julie Linderman is a student in an organized health care education/training program specialist in Dallas, TX, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Linderman received a total of $2,238 from 22 pharmaceutical and/or device companies across 124 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Linderman is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration $2,238 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$2,238
Total received (2018-2024)
Avg $320/year across 7 years
Top 14% in TX for student in an organized health care education/training program
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
22
Companies
124
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$499
2023
$308
2022
$364
2021
$233
2020
$225
2019
$351
2018
$258

Payments by company (2024)

Corium, LLC
$155
IRONSHORE PHARMACEUTICALS INC.
$85
PFIZER INC.
$84
Tris Pharma Inc
$46
SANOFI PASTEUR INC.
$37
AstraZeneca Pharmaceuticals LP
$22
GlaxoSmithKline, LLC.
$21
Cranial Technologies, Inc
$17
Verrica Pharmaceuticals Inc.
$17
Aytu BioPharma, Inc.
$15
Top 3 companies account for 65.1% of 2024 payments
All-time payments by company (2018-2024) ›
Tris Pharma Inc
$577
PFIZER INC.
$217
Neos Therapeutics, LP
$195
GlaxoSmithKline, LLC.
$157
Corium, LLC
$155
Cranial Technologies, Inc
$145
SANOFI PASTEUR INC.
$114
ARBOR PHARMACEUTICALS, INC.
$110
Ironshore Pharmaceuticals Inc.
$100
IRONSHORE PHARMACEUTICALS INC.
$85
AstraZeneca Pharmaceuticals LP
$63
Shire North American Group Inc
$48
Mission Pharmacal Company
$41
Genentech USA, Inc.
$39
kaleo, Inc.
$35
Adlon Therapeutics L.P.
$29
Boston Scientific Corporation
$28
iScreen Vision Inc.
$27
Supernus Pharmaceuticals, Inc.
$25
Merck Sharp & Dohme Corporation
$17
Verrica Pharmaceuticals Inc.
$17
Aytu BioPharma, Inc.
$15
Top 3 companies account for 44.1% of all-time payments
Associated products mentioned in payments ›
ADHANSIA XR · AUVI-Q · Adzenys XR-ODT · Azstarys · BEXSERO · BEYFORTUS · Cotempla XR-ODT · Doc Band · Dyanavel XR · EUCRISA · Eletone · Evekeo ODT · FLUMIST QUADRIVALENT · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · GARDASIL 9 · JORNAY PM · Karbinal · MENQUADFI · MYDAYIS · Otovel · PREVNAR 13 · PREVNAR 20 · Prednisolone 25 · QELBREE · Quillichew ER · Quillivant · Quillivant XR · TRUMENBA · VAXELIS · VYVANSE · WATCHMAN Access System · Xofluza · YCANTH
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a student in an organized health care education/training program specialist in Dallas?
Compare student in an organized health care education/training programs in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse student in an organized health care education/training programs nearby

Geographic Context

Student in an organized health care education/training programs in nearby ZIP areas
5,921
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
PARKLAND HEALTH & HOSPITAL SYSTEM
1.7 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Linderman is a student in an organized health care education/training program specialist, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Linderman receive payments from pharmaceutical companies?
Yes. Dr. Linderman received a total of $2,238 from 22 companies across 124 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Linderman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Student In An Organized Health Care Education/training Programs in Dallas
Browse student in an organized health care education/training programs in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Student In An Organized Health Care Education/training Programs in TX
Student in an organized health care education/training programs ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Student In An Organized Health Care Education/training Programs in TX
Which TX student in an organized health care education/training programs receive the most from drug and device companies.
By company
Tris Pharma Inc Payments to Doctors
See all physicians who received payments from Tris Pharma Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Neos Therapeutics, LP Payments to Doctors
See all physicians who received payments from Neos Therapeutics, LP.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →